Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels

Cellular Physiology and Biochemistry

Volumn 22, Issue 1-4, 2008, Pages 57-68

  Illek, Beate ^b   Maurisse, Rosalie ^a   Wahler, Logan ^b   Kunzelmann, Karl ^c   Fischer, Horst ^b   Gruenert, Dieter C ^a,d,e  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Cell line; Complementation; Episomal expression of full length CFTR; Polarized CF bronchial epithelia; Transfection

Indexed keywords

MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BRONCHUS MUCOSA; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 51149117224     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149783     Document Type: Article

References (75)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
2. Kunzelmann K, Lei DC, Eng K, Escobar LC, Koslowsky T, Gruenert DC: Epithelial cell specific properties and genetic complementation in a delta F508 cystic fibrosis nasal polyp cell line. In Vitro Cell Dev Biol Anim 1995;31:617-624.
3. McNicholas CM, Guggino WB, Schwiebert EM, Hebert SC, Giebisch G, Egan ME: Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. Proc Natl Acad Sci U S A 1996;93:8083-8088.
4. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
5. Consortium TCFGA: Cystic Fibrosis Mutation Database. In, 2007.
6. Collins FS: Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-783.
7. Tsui L-C: The spectrum of cystic fibrosis mutations. Trends in Genet 1992;8:392-398.
8. Aitken ML, Fiel SB: Cystic fibrosis. J Clin Invest 1993;91:225-234.
9. Denning GM, Ostedgaard LS, Welsh MJ: Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol 1992;118:551-559.
10. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR, Boucher RC: Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 2005;16:2154-2167.
11. Widdicombe JH, Welsh MJ, Finkbeiner WE: Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc Natl Acad Sci USA 1985;82:6167-6171.
12. Gruenert DC, Basbaum CB, Widdicombe JH: Long-term culture of normal and cystic fibrosis epithelial cells grown under serum-free conditions. In Vitro Cell Dev Biol 1990;26:411-418.
13. Gruenert DC, Finkbeiner WE, Widdicombe JH: Culture and transformation of human airway epithelial cells. Am J Physiol 1995;268:L347-360.
14. Gruenert DC, Willems M, Cassiman JJ, Frizzell RA: Established cell lines used in cystic fibrosis research. J Cyst Fibros 2004;3 Suppl 2:191-196.
15. Kalin N, Claass A, Sommer M, Puchelle E, Tummler B: DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 1999;103:1379-1389.
16. Widdicombe JH, Coleman DL, Finkbeiner WE, Tuet I: Electrical properties of monolayers cultured from cells of human tracheal mucosa. J Appl Physiol 1985;58:1729-1735.
17. Yankaskas JR, Cotton CU, Knowles MR, Gatzy JT, Boucher RC: Culture of human nasal epithelial cells on collagen matrix supports. Am Rev Respir Dis 1985;132:1281-1287.
18. Yankaskas JR, Knowles MR, Gatzy JT, Boucher RC: Persistence of abnormal chloride ion permeability in cystic fibrosis nasal epithelial cells in heterologous culture. Lancet 1985;1:954-956.
19. Cozens AL, Yezzi MJ, Chin L, Simon EM, Finkbeiner WE, Wagner JA, Gruenert DC: Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci U S A 1992;89:5171-5175.
20. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;10:38-47.
21. Cozens AL, Yezzi MJ, Yamaya M, Steiger D, Wagner JA, Garber SS, Chin L, Simon EM, Cutting GR, Gardner P, et al.: A transformed human epithelial cell line that retains tight junctions post crisis. In Vitro Cell Dev Biol 1992;28A:735-744.
22. Gruenert DC, Basbaum CB, Welsh MJ, Li M, Finkbeiner WE, Nadel JA: Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci U S A 1988;85:5951-5955.
23. Jefferson DM, Valentich JD, Marini FC, Grubman SA, Iannuzzi MC, Dorkin HL, Li M, Klinger KW, Welsh MJ: Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines. Am J Physiol 1990;259:L496-L505.
24. Jetten AM, Yankaskas JR, Stutts MJ, Willumsen NJ, Boucher RC: Persistence of abnormal chloride conductance regulation in transformed cystic fibrosis epithelia. Science 1989;244:1472-1475.
25. Kunzelmann K, Schwiebert EM, Zeitlin PL, Kuo WL, Stanton BA, Gruenert DC: An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol 1993;8:522-529.
26. Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, Brooks MW, Fleming MD, Olsen JC, Miller SW, Weinberg RA, Hahn WC: Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 2002;21:4577-4586.
27. Scholte BJ, Kansen M, Hoogeveen AT, Willemse R, Rhim JS, van der Kamp AW, Bijman J: Immortalization of nasal polyp epithelial cells from cystic fibrosis patients. Exp Cell Res 1989;182:559-571.
28. Vaughan MB, Ramirez RD, Wright WE, Minna JD, Shay JW: A three-dimensional model of differentiation of immortalized human bronchial epithelial cells. Differentiation 2006;74:141-148.
29. Wei X, Eisman R, Xu J, Harsch AD, Mulberg AE, Bevins CL, Glick MC, Scanlin TF: Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells. J Cell Physiol 1996;168:373-384.
30. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G, Kieffer KA, Craig R, Guggino WB: A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 1991;4:313-319.
31. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE: Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-834.
32. Kartner N, Hanrahan JW, Jensen TJ, Naismith AL, Sun SZ, Ackerley CA, Reyes EF, Tsui LC, Rommens JM, Bear CE, et al.: Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 1991;64:681-691.
33. Rommens JM, Dho S, Bear CE, Kartner N, Kennedy D, Riordan JR, Tsui LC, Foskett JK: cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A 1991;88:7500-7504.
34. Schiavi SC, Abdelkader N, Reber S, Pennington S, Narayana R, McPherson JM, Smith AE, Hoppe Ht, Cheng SH: Biosynthetic and growth abnormalities are associated with high-level expression of CFTR in heterologous cells. Am J Physiol 1996;270:C341-351.
35. Stutts MJ, Gabriel SE, Olsen JC, Gatzy JT, O'Connell TL, Price EM, Boucher RC: Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts. J Biol Chem 1993;268:20653-20658.
36. Farinha CM, Penque D, Roxo-Rosa M, Lukacs G, Dormer R, McPherson M, Pereira M, Bot AG, Jorna H, Willemsen R, Dejonge H, Heda GD, Marino CR, Fanen P, Hinzpeter A, Lipecka J, Fritsch J, Gentzsch M, Edelman A, Amaral MD: Biochemical methods to assess CFTR expression and membrane localization. J Cyst Fibros 2004;3 Suppl 2:73-77.
37. Brezillon S, Hamm H, Heilmann M, Schafers HJ, Hinnrasky J, Wagner TO, Puchelle E, Tummler B: Decreased expression of the cystic fibrosis transmembrane conductance regulator protein in remodeled airway epithelium from lung transplanted patients. Hum Pathol 1997;28:944-952.
38. Jacquot J, Puchelle E, Hinnrasky J, Fuchey C, Bettinger C, Spilmont C, Bonnet N, Dieterle A, Dreyer D, Pavirani A, et al.: Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 1993;6:169-176.
39. Farmen SL, Karp PH, Ng P, Palmer DJ, Koehler DR, Hu J, Beaudet AL, Zabner J, Welsh MJ: Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am J Physiol Lung Cell Mol Physiol 2005;289:L1123-1130.
40. Trapnell BC, Chu CS, Paakko PK, Banks TC, Yoshimura K, Ferrans VJ, Chernick MS, Crystal RG: Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci U S A 1991;88:6565-6569.
41. Cheng SH, Fang SL, Zabner J, Marshall J, Piraino S, Schiavi SC, Jefferson DM, Welsh MJ, Smith AE: Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression. Am J Physiol 1995;268:L615-624.
42. Dragomir A, Bjorstad J, Hjelte L, Roomans GM: Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2004;322:447-451.
43. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ: Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004;304:600-602.
44. Lipecka J, Norez C, Bensalem N, Baudouin-Legros M, Planelles G, Becq F, Edelman A, Davezac N: Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J Pharmacol Exp Ther 2006;317:500-505.
45. Mall M, Kunzelmann K: Correction of the CF defect by curcumin: hypes and disappointments. Bioessays 2005;27:9-13.
46. Fischer H, Illek B, Finkbeiner WE, Widdicombe JH: Basolateral Cl channels in primary airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol 2007;292:L1432-1443.
47. Cunningham SA, Worrell RT, Benos DJ, Frizzell RA: cAMP-stimulated ion currents in Xenopus oocytes expressing CFTR cRNA. Am J Physiol 1992;262:C783-788.
48. Baudouin-Legros M, Hinzpeter A, Jaulmes A, Brouillard F, Costes B, Fanen P, Edelman A: Cell-specific posttranscriptional regulation of CFTR gene expression via influence of MAPK cascades on 3′UTR part of transcripts. Am J Physiol Cell Physiol 2005;289:C1240-1250.
49. Davies WL, Vandenberg JI, Sayeed RA, Trezise AE: Cardiac expression of the cystic fibrosis transmembrane conductance regulator involves novel exon 1 usage to produce a unique amino-terminal protein. J Biol Chem 2004;279:15877-15887.
50. Lei DC, Kunzelmann K, Koslowsky T, Yezzi MJ, Escobar LC, Xu Z, Ellison AR, Rommens JM, Tsui LC, Tykocinski M, Gruenert DC: Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther 1996;3:427-436.
51. Bruscia E, Sangiuolo F, Sinibaldi P, Goncz KK, Novelli G, Gruenert DC: Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther 2002;9:683-685.
52. Gluzman Y: SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981;23:175-182.
53. Small MB, Gluzman Y, Ozer HL: Enhanced transformation of human fibroblasts by origin-defective SV40. Nature 1982;296:671-675.
54. Hipper A, Mall M, Greger R, Kunzelmann K: Mutations in the putative pore-forming domain of CFTR do not change anion selectivity of the cAMP activated Cl- conductance. FEBS Lett 1995;374:312-316.
55. Mall M, Kunzelmann K, Hipper A, Busch AE, Greger R: cAMP stimulation of CFTR-expressing Xenopus oocytes activates a chromanol-inhibitable K+ conductance. Pflugers Arch 1996;432:516-522.
56. Lechner JF, LaVeck MA: A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Culture Methods 1985;9:43-48.
57. Goncz KK, Kunzelmann K, Xu Z, Gruenert DC: Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments. Hum Mol Genet 1998;7:1913-1919.
58. Freeman WM, Walker SJ, Vrana KE: Quantitative RT-PCR: pitfalls and potential. Biotechniques 1999;26:112-122, 124-125.
59. Illek B, Fischer H: Flavonoids stimulate Cl conductance of human airway epithelium in vitro and in vivo. Am J Physiol 1998;275:L902-910.
60. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS: Discovery of glycine hydrazide poreoccluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 2004;124:125-137.
61. Sheppard DN, Welsh MJ: Effect of ATPsensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol 1992;100:573-591.
62. Ehrhardt C, Collnot EM, Baldes C, Becker U, Laue M, Kim KJ, Lehr CM: Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o. Cell Tissue Res 2006;323:405-415.
63. Ma T, Vetrivel L, Yang H, Pedemonte N, Zegarra-Moran O, Galietta LJ, Verkman AS: High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J Biol Chem 2002;277:37235-37241.
64. Loffing-Cueni D, Loffing J, Shaw C, Taplin AM, Govindan M, Stanton CR, Stanton BA: Trafficking of GFP-tagged DeltaF508-CFTR to the plasma membrane in a polarized epithelial cell line. Am J Physiol Cell Physiol 2001;281:C1889-1897.
65. Maitra R, Shaw CM, Stanton BA, Hamilton JW: Increased functional cell surface expression of CFTR and DeltaF508-CFTR by the anthracycline doxorubicin. Am J Physiol Cell Physiol 2001;280:C1031-1037.
66. Bebok Z, Venglarik CJ, Panczel Z, Jilling T, Kirk KL, Sorscher EJ: Activation of DeltaF508 CFTR in an epithelial monolayer. Am J Physiol 1998;275:C599-607.
67. Van Goor F, Straley KS, Cao D, Gonzalez J, Hadida S, Hazlewood A, Joubran J, Knapp T, Makings LR, Miller M, Neuberger T, Olson E, Panchenko V, Rader J, Singh A, Stack JH, Tung R, Grootenhuis PD, Negulescu P: Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol Lung Cell Mol Physiol 2006;290:L1117-1130.
68. Howard M, Fischer H, Roux J, Santos BC, Gullans SR, Yancey PH, Welch WJ: Mammalian osmolytes and Snitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function. J Biol Chem 2003;278:35159-35167.
69. Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, Verkman AS: Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 2005;115:2564-2571.
70. Sousa M, Ousingsawat J, Seitz R, Puntheeranurak S, Regalado A, Schmidt A, Grego T, Jansakul C, Amaral MD, Schreiber R, Kunzelmann K: An extract from the medicinal plant Phyllanthus acidus and its isolated compounds induce airway chloride secretion: A potential treatment for cystic fibrosis. Mol Pharmacol 2007;71:366-376.
71. Galietta LV, Jayaraman S, Verkman AS: Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am J Physiol Cell Physiol 2001;281:C1734-1742.
72. Haws CM, Nepomuceno IB, Krouse ME, Wakelee H, Law T, Xia Y, Nguyen H, Wine JJ: Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 1996;270:C1544-1555.
73. Pedemonte N, Diena T, Caci E, Nieddu E, Mazzei M, Ravazzolo R, Zegarra-Moran O, Galietta LJ: Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations. Mol Pharmacol 2005;68:1736-1746.
74. Illek B, Zhang L, Lewis NC, Moss RB, Dong JY, Fischer H: Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am J Physiol 1999;277:C833-839.
75. Tabcharani JA, Low W, Elie D, Hanrahan JW: Low-conductance chloride channel activated by cAMP in the epithelial cell line T84. FEBS Lett 1990;270:157-164.